FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical and pharmaceutical industry, specifically a method of producing lenalidomide intermediate of formula (10) by reacting 3-nitrophthalaldehyde with 3-amino-2,6-piperidinedion in the presence of a reducing agent and an organic acid in a medium of a chlorinated organic solvent, and further conversion of the intermediate into lenalidomide by reduction of the nitro group.
(10).
EFFECT: present method is environmentally friendly, safe and provides for use of readily available raw material.
10 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF TUMOR NECROSIS FACTOR- LEVEL | 1997 |
|
RU2177944C2 |
SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF DECREASE OF TUMOR NECROSIS FACTOR-α LEVEL | 1997 |
|
RU2595250C1 |
NANO-AMORPHOUS FORM (RS)-3-(4-AMINO-1-OXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)PIPERIDINE-2,6-DIONE (VERSIONS), A METHOD FOR PRODUCTION THEREOF AND USE FOR TREATING IMMUNOLOGICAL OR ONCOLOGICAL DISEASES | 2019 |
|
RU2723624C1 |
METHOD OF PRODUCING SOFOSBUVIR AND PHOSPHORAMIDATES | 2020 |
|
RU2740058C1 |
PYPERIDINYL NAPHTHYLUXIC ACIDS | 2012 |
|
RU2628083C2 |
METHOD FOR TRIMETHYL SUBSTITUTED FURODIHYDROQUINOLINES SYNTHESIS | 2016 |
|
RU2614248C1 |
METHOD OF ENANTIOSELECTIVE SYNTHESIS OF INTERMEDIATE COMPOUNDS USED IN SYNTHESIS OF FLAVONE-SUBSTITUTED PYRROLIDINES | 2006 |
|
RU2404965C2 |
COMPOUND (6-{[(1S)-1(5-FLUORO-4-OXO-3-PHENYL-3,4-DIHYDROQUINAZOLIN-2-YL)PROPYL]AMINO}-9H-PURIN-9-YL)METHYL ACETATE AS INHIBITOR OF P110δ- DELTA ISOFORM OF PHOSPHOINOSITIDE-3-KINASE (PI3K), METHODS FOR ITS PRODUCTION (OPTIONS) AND APPLICATIONS | 2018 |
|
RU2675237C1 |
PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
BENZO-DERIVATIVES WITH SIX-MEMBERED RING AS DPP-4 INHIBITOR AND USE THEREOF | 2015 |
|
RU2702644C2 |
Authors
Dates
2020-08-26—Published
2020-05-19—Filed